Congressman Tom Marino (R-PA) has been picked to head the National Drug Control Policy. According to the New York Daily News, Marino is seen as a lackey of the pharmaceutical industry.
President Trump’s pick to be the nation’s next drug czar was the architect behind a bill making it harder for federal agents to go after drug companies flooding the market with addictive opioids. Critics questioned Rep. Tom Marino (R-Pa.) and his cozy ties to the pharmaceutical industry on Sunday — with some claiming he has no interest in alleviating the nation’s worsening opioid epidemic. “This is a very serious question,” Senate Minority Leader Charles Schumer (D-N.Y.) told the Daily News. “I’m going to meet with Mr. Marino. And I hope to ask him about this because it’s very troubling.”
What did Marino's bill do exactly?
Marino’s 2016 industry-friendly Ensuring Patient Access and Effective Drug Enforcement Act disarmed the Drug Enforcement Administration in its fight against companies suspected of dispensing excessive amounts of powerful prescription medications, according to a joint report from the Washington Post and "60 Minutes."